オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/04/16 | 3,030 | 3,070 | 2,704 | 2,810 | -189 | -6.3% | 11,109,600 |
2019/04/15 | 2,745 | 3,025 | 2,744 | 2,999 | +304 | +11.3% | 13,993,700 |
2019/04/12 | 3,350 | 3,385 | 2,695 | 2,695 | -700 | -20.6% | 17,096,100 |
2019/04/11 | 3,475 | 3,765 | 3,235 | 3,395 | +330 | +10.8% | 22,335,600 |
2019/04/10 | 3,065 | 3,065 | 3,065 | 3,065 | +500 | +19.5% | 75,400 |
2019/04/09 | 2,565 | 2,565 | 2,565 | 2,565 | +500 | +24.2% | 132,500 |
2019/04/08 | 1,792 | 2,120 | 1,752 | 2,065 | +313 | +17.9% | 11,069,700 |
2019/04/05 | 1,800 | 1,910 | 1,702 | 1,752 | -76 | -4.2% | 12,700,000 |
2019/04/04 | 2,013 | 2,125 | 1,824 | 1,828 | -154 | -7.8% | 12,436,900 |
2019/04/03 | 2,338 | 2,398 | 1,868 | 1,982 | -208 | -9.5% | 14,386,100 |
2019/04/02 | 2,544 | 2,675 | 2,190 | 2,190 | -500 | -18.6% | 9,908,800 |
2019/04/01 | 2,970 | 3,460 | 2,690 | 2,690 | -700 | -20.6% | 6,750,900 |
2019/03/29 | 3,475 | 3,525 | 3,305 | 3,390 | +140 | +4.3% | 3,412,200 |
2019/03/28 | 3,065 | 3,395 | 3,035 | 3,250 | +120 | +3.8% | 2,943,200 |
2019/03/27 | 2,934 | 3,160 | 2,810 | 3,130 | +201 | +6.9% | 3,560,100 |
2019/03/26 | 2,667 | 2,990 | 2,624 | 2,929 | +412 | +16.4% | 5,207,600 |
2019/03/25 | 2,429 | 2,756 | 2,403 | 2,517 | -12 | -0.5% | 4,818,500 |
2019/03/22 | 2,985 | 3,075 | 2,500 | 2,529 | -666 | -20.8% | 7,671,100 |
2019/03/20 | 3,360 | 3,575 | 3,190 | 3,195 | -235 | -6.9% | 2,065,600 |
2019/03/19 | 3,270 | 3,630 | 2,940 | 3,430 | +30 | +0.9% | 5,513,200 |
2019/03/18 | 3,565 | 3,740 | 3,335 | 3,400 | -235 | -6.5% | 2,074,600 |
2019/03/15 | 3,555 | 3,980 | 3,535 | 3,635 | -165 | -4.3% | 2,825,500 |
2019/03/14 | 4,390 | 4,410 | 3,670 | 3,800 | -465 | -10.9% | 3,360,800 |
2019/03/13 | 3,615 | 4,360 | 3,535 | 4,265 | +605 | +16.5% | 6,763,600 |
2019/03/12 | 3,560 | 3,980 | 3,385 | 3,660 | -40 | -1.1% | 5,903,900 |
2019/03/11 | 3,345 | 3,700 | 3,140 | 3,700 | +700 | +23.3% | 6,150,800 |
2019/03/08 | 2,497 | 3,000 | 2,473 | 3,000 | +500 | +20% | 7,532,600 |
2019/03/07 | 2,345 | 2,500 | 2,304 | 2,500 | +95 | +4% | 2,345,700 |
2019/03/06 | 2,351 | 2,490 | 2,231 | 2,405 | +95 | +4.1% | 2,967,200 |
2019/03/05 | 2,311 | 2,392 | 2,245 | 2,310 | -51 | -2.2% | 1,611,700 |
2019/03/04 | 2,500 | 2,553 | 2,345 | 2,361 | +50 | +2.2% | 2,868,400 |
2019/03/01 | 2,246 | 2,335 | 2,222 | 2,311 | +103 | +4.7% | 1,629,700 |
2019/02/28 | 2,339 | 2,355 | 2,170 | 2,208 | -171 | -7.2% | 2,699,100 |
2019/02/27 | 2,165 | 2,394 | 2,121 | 2,379 | +243 | +11.4% | 6,684,700 |
2019/02/26 | 2,400 | 2,547 | 2,076 | 2,136 | -124 | -5.5% | 7,216,300 |
2019/02/25 | 1,900 | 2,260 | 1,868 | 2,260 | +400 | +21.5% | 5,818,300 |
2019/02/22 | 1,750 | 1,881 | 1,725 | 1,860 | +100 | +5.7% | 1,637,600 |
2019/02/21 | 1,850 | 1,865 | 1,727 | 1,760 | -13 | -0.7% | 1,975,200 |
2019/02/20 | 1,749 | 1,814 | 1,693 | 1,773 | +96 | +5.7% | 1,886,900 |
2019/02/19 | 1,782 | 1,837 | 1,673 | 1,677 | -105 | -5.9% | 2,091,800 |
2019/02/18 | 1,771 | 1,838 | 1,716 | 1,782 | +29 | +1.7% | 2,156,400 |
2019/02/15 | 1,721 | 1,790 | 1,694 | 1,753 | +29 | +1.7% | 2,486,200 |
2019/02/14 | 1,810 | 1,908 | 1,662 | 1,724 | -129 | -7% | 7,267,200 |
2019/02/13 | 1,650 | 1,912 | 1,580 | 1,853 | +279 | +17.7% | 12,552,200 |
2019/02/12 | 1,410 | 1,574 | 1,380 | 1,574 | +300 | +23.5% | 5,803,500 |
2019/02/08 | 1,261 | 1,307 | 1,223 | 1,274 | -72 | -5.3% | 2,062,000 |
2019/02/07 | 1,372 | 1,389 | 1,293 | 1,346 | -40 | -2.9% | 2,912,800 |
2019/02/06 | 1,280 | 1,392 | 1,261 | 1,386 | +159 | +13% | 4,718,400 |
2019/02/05 | 1,253 | 1,268 | 1,200 | 1,227 | -26 | -2.1% | 1,610,000 |
2019/02/04 | 1,180 | 1,276 | 1,176 | 1,253 | +92 | +7.9% | 2,707,300 |
1551~
1600
件表示中 / 2861件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
扶桑薬 | 220,300円 | +1.6% | -12.7% | 4.09% | 8.18倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム